Targeting FtsZ for Antituberculosis Drug Discovery: Noncytotoxic Taxanes as Novel Antituberculosis Agents
- 21 December 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (2) , 463-466
Abstract
Screening of 120 taxanes identified a number of compounds that exhibited significant antituberculosis activity. Rational optimization of selected compounds led to the discovery that the C-seco-taxane-multidrug-resistance (MDR) reversal agents (C-seco-TRAs) are noncytotoxic at the upper limit of solubility and detection (>80 μM), while maintaining MIC99 values of 1.25−2.5 μM against drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis (MTB). Treatment of MTB cells with TRA 3aa and 10a at the MIC caused filamentation and prolongation of the cells, a phenotypic response to FtsZ inactivation.Keywords
This publication has 9 references indexed in Scilit:
- Design, Synthesis and Structure−Activity Relationships of Novel Taxane-Based Multidrug Resistance Reversal AgentsJournal of Medicinal Chemistry, 2005
- Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators.2004
- Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023Cancer Chemotherapy and Pharmacology, 2004
- Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.2003
- Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.2002
- The Chemistry of Taxol and Related Taxoids2002
- Issues Facing TB Control (7) Multiple Drug-Resistant TuberculosisScottish Medical Journal, 2000
- New taxanes as highly efficient reversal agents for multi-drug resistance in cancer cellsBioorganic & Medicinal Chemistry Letters, 1998
- FtsZ ring structure associated with division in Escherichia coliNature, 1991